Muto MG - Search Results

1

Preoperative serum CA-125 levels in borderline tumors of the ovary.

Rice LW, Lage JM, Berkowitz RS, Goodman A, Muto MG, Knapp RC, Bell DA. Rice LW, et al. Among authors: muto mg. Gynecol Oncol. 1992 Aug;46(2):226-9. doi: 10.1016/0090-8258(92)90260-p. Gynecol Oncol. 1992. PMID: 1500026

2

The role of cytoreductive surgery in the management of stage IV epithelial ovarian carcinoma.

Goodman HM, Harlow BL, Sheets EE, Muto MG, Brooks S, Steller M, Knapp RC, Berkowitz RS. Goodman HM, et al. Among authors: muto mg. Gynecol Oncol. 1992 Sep;46(3):367-71. doi: 10.1016/0090-8258(92)90234-a. Gynecol Oncol. 1992. PMID: 1526516

3

Intraperitoneal radioimmunotherapy of refractory ovarian carcinoma utilizing iodine-131-labeled monoclonal antibody OC125.

Muto MG, Finkler NJ, Kassis AI, Howes AE, Anderson LL, Lau CC, Zurawski VR Jr, Weadock K, Tumeh SS, Lavin P, et al. Muto MG, et al. Gynecol Oncol. 1992 Jun;45(3):265-72. doi: 10.1016/0090-8258(92)90302-y. Gynecol Oncol. 1992. PMID: 1612502 Clinical Trial.

4

Gestational trophoblastic disease of the fallopian tube.

Muto MG, Lage JM, Berkowitz RS, Goldstein DP, Bernstein MR. Muto MG, et al. J Reprod Med. 1991 Jan;36(1):57-60. J Reprod Med. 1991. PMID: 1848902

5

Human anti-murine antibody responses in ovarian cancer patients undergoing radioimmunotherapy with the murine monoclonal antibody OC-125.

Muto MG, Finkler NJ, Kassis AI, Lepisto EM, Knapp RC. Muto MG, et al. Gynecol Oncol. 1990 Aug;38(2):244-8. doi: 10.1016/0090-8258(90)90049-q. Gynecol Oncol. 1990. PMID: 2387541

6

Influence of human antimurine antibody on CA 125 levels in patients with ovarian cancer undergoing radioimmunotherapy or immunoscintigraphy with murine monoclonal antibody OC 125.

Muto MG, Lepisto EM, Van den Abbeele AD, Knapp RC, Kassis AI. Muto MG, et al. Am J Obstet Gynecol. 1989 Nov;161(5):1206-12. doi: 10.1016/0002-9378(89)90667-4. Am J Obstet Gynecol. 1989. PMID: 2686446

7

Intraperitoneal radiolabeled OC 125 in patients with advanced ovarian cancer.

Finkler NJ, Muto MG, Kassis AI, Weadock K, Tumeh SS, Zurawski VR Jr, Knapp RC. Finkler NJ, et al. Among authors: muto mg. Gynecol Oncol. 1989 Sep;34(3):339-44. doi: 10.1016/0090-8258(89)90169-8. Gynecol Oncol. 1989. PMID: 2767526

8

Characterization of human ovarian surface epithelial cells immortalized by human papilloma viral oncogenes (HPV-E6E7 ORFs).

Tsao SW, Mok SC, Fey EG, Fletcher JA, Wan TS, Chew EC, Muto MG, Knapp RC, Berkowitz RS. Tsao SW, et al. Among authors: muto mg. Exp Cell Res. 1995 Jun;218(2):499-507. doi: 10.1006/excr.1995.1184. Exp Cell Res. 1995. PMID: 7796885

9

Evidence for a multifocal origin of papillary serous carcinoma of the peritoneum.

Muto MG, Welch WR, Mok SC, Bandera CA, Fishbaugh PM, Tsao SW, Lau CC, Goodman HM, Knapp RC, Berkowitz RS. Muto MG, et al. Cancer Res. 1995 Feb 1;55(3):490-2. Cancer Res. 1995. PMID: 7834614

10

p53 gene mutation in human borderline epithelial ovarian tumors.

Wertheim I, Muto MG, Welch WR, Bell DA, Berkowitz RS, Mok SC. Wertheim I, et al. Among authors: muto mg. J Natl Cancer Inst. 1994 Oct 19;86(20):1549-51. doi: 10.1093/jnci/86.20.1549. J Natl Cancer Inst. 1994. PMID: 7932812 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138 results

Search Page

Filters